Agios Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:AGIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -290.76 M-407.32 M-309.48 M-296.06 M-389.84 M-372.98 M -360.6 M Cash from investing activities 75.75 M1.25 B243.26 M239.57 M363.44 M377.18 M 367.15 M Cash from financing activities 261.52 M-765.77 M2.35 M5.43 M14.44 M8.68 M 12.22 M Free cash flow -290.76 M-407.32 M-309.48 M-296.06 M-389.84 M-377.29 M -365.25 M

News

Agios Pharmaceuticals: Indication Stacking Is Creating A Commercial Flywheel (NASDAQ:AGIO)

AGIO Q2 Earnings Beat Estimates, Revenues Increase Year Over Year

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates

The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals

Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?

Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

AGIO Shares Sink Nearly 7% After Scrapping the Tebapivat SCD Program

Stock Indexes Settle Higher as Chipmakers Soar

Agios Reports Neutral Sickle Cell Data, Decides To Stop Development - Agios Pharmaceuticals (NASDAQ:AGIO)

Strength in Chipmakers Boosts Stocks